-
-
n this issue: Tamoxifen and CYP2D6 inhibitors, FDA Actions, and FDA Warnings.
-
Robotic surgical procedures are increasingly being incorporating into the surgical management of gynecologic cancers, particularly early-stage endometrial and cervical cancer.
-
A large retrospective cohort time series compared strategies to prevent infectious complications of medical abortion at Planned Parenthood Federation of America (PPFA)-affiliated clinics.
-
June seems to have been magnesium sulfate month in both the Obstetrics & Gynecology and American Journal of Obstetrics & Gynecology journals.
-
The raloxifene use for the heart (RUTH) trial was an international randomized, placebo-controlled trial that enrolled 10,101 postmenopausal women in two groups, one at high risk for coronary heart disease, and one with established coronary heart disease.
-
A large prospective randomized trial (n = 2812 women) was retrospectively analyzed to look at contraceptive efficacy and weight/BMI.
-
-
In this issue: Comparing blood pressure medications, determining optimal length of androgen-deprivation therapy, red yeast rice for LDL reduction, and FDA Actions.
-
About 30 years ago (so long ago that I can't remember the exact year), I began to edit a monthly newsletter devoted to reproductive medicine.